Tag: Autoimmune diseases

AstraZeneca to acquire Gracell Biotechnologies for $1.2bn to expand cell therapy capabilities

businessnewstoday- January 2, 2024

AstraZeneca has announced a definitive agreement to acquire Gracell Biotechnologies Inc. (Gracell, NASDAQ: GRCL) for an upfront cash payment of $1.0 billion, representing a 62% ... Read More

Immutep taps Charles River for IMP761 LAG-3 antibody preclinical study

businessnewstoday- May 29, 2023

Immutep Limited, an Australian biotech company specializing in LAG-3 immunotherapies for cancer and autoimmune diseases, has partnered with Charles River Laboratories to conduct a GLP ... Read More

Gilead Sciences partners with EVOQ Therapeutics on immunotherapies

Raghuram Kadari- January 4, 2023

American biopharma major Gilead Sciences and immunotherapy company EVOQ Therapeutics have entered into a partnership to develop and market immunotherapy products. Under the collaboration and ... Read More

Amgen to acquire American biopharma company ChemoCentryx for $3.7bn

pallavi123- August 4, 2022

Amgen has agreed to acquire ChemoCentryx, a biopharma company engaged in developing medications for inflammatory and autoimmune diseases and cancer, in an all-cash deal worth ... Read More

French biotech company Step Pharma raises €35m in a Series B round

pallavi123- March 24, 2021

Step Pharma has raised €35 million in a Series B financing round for advancing STP938, its lead CTPS1 inhibitor into clinical development for the treatment ... Read More

Pandion bags $795m deal with Astellas for pancreas-targeted immunomodulators

pharmanewsdaily- November 2, 2019

Pandion Therapeutics has bagged a $795 million worth license and collaboration deal with Japanese pharma company Astellas Pharma for the research, development, and commercialization of ... Read More

Alexion to acquire Boston-based Syntimmune in $1.2bn deal

pharmanewsdaily- September 30, 2018

Alexion acquisition of Syntimmune : US pharma company Alexion Pharmaceuticals has signed a deal of around $1.2 billion to acquire Syntimmune, a Boston-based clinical-stage biotech ... Read More

Researchers find ACE inhibitors can stop memory loss in lupus patients

pharmanewsdaily- September 8, 2018

Researchers at the Feinstein Institute for Medical Research in New York claim that ACE inhibitors - a class of drugs that are widely used in ... Read More